Overall patient sentiment: strongly positive on Trustpilot, rougher on BBB
The consistent theme across DirectMeds patient reviews on Trustpilot is that the medication works as expected — appetite suppression kicks in, weight loss follows, and the overall experience with compounded semaglutide closely mirrors what patients who took brand-name versions report. This makes sense because the active molecule is the same.
Where DirectMeds specifically earns praise: pricing transparency, the straightforwardness of the intake process, and medication arriving properly packaged. Where complaints cluster — and this is worth saying plainly rather than softening it — is billing on multi-month commitments and cancellation difficulty, which is serious enough that DirectMeds carries a Better Business Bureau rating of F built on 100+ complaints. That's a real split between two independent review sources, not a minor asterisk, and it's covered in full in our DirectMeds legitimacy investigation.
Check your eligibility at DirectMeds
Free eligibility check. Licensed physician review. Compounded semaglutide from $249/month.
Check eligibility at DirectMeds →What patients consistently praise
- Pricing: The most common positive is simply that the cost is dramatically lower than brand-name alternatives. Patients who were paying $900+/month for Ozempic or Wegovy and switched to DirectMeds at $249–$297/month report the same clinical experience at a fraction of the cost
- Medication effectiveness: The overwhelming majority of patients who complete titration to therapeutic doses report significant appetite suppression and meaningful weight loss — consistent with clinical trial data for semaglutide
- Intake process: Most patients find the online intake straightforward and report physician review happening within 24–48 hours
- Packaging and delivery: Medications arrive refrigerated and properly labeled, which patients note as a positive differentiator from lower-quality alternatives
Common complaints — and why this is more than a minor asterisk
Most reviews of DirectMeds mention complaints in passing. We'd rather be specific, because the pattern is real enough that it shows up as an F rating on the Better Business Bureau, not just a handful of one-star Trustpilot reviews:
- Cancellation and billing: The most consistent complaint, and the one driving the BBB rating — patients report being told a balance is owed after they believed they'd canceled, confusion over multi-month billing commitments, and difficulty reaching support to confirm cancellation actually went through
- Customer support response times: A related, more general complaint across GLP-1 telehealth platforms including DirectMeds — difficulty reaching support quickly when questions arise, particularly about side effects or dose adjustments
- Shipping delays and errors: First orders in particular can take longer than the stated timeframe, and at least one documented case involved the wrong medication being shipped (semaglutide sent when tirzepatide was ordered)
- Titration guidance: Some patients report wanting more proactive guidance on dose increases rather than needing to initiate the conversation themselves
Patient results — what people actually report losing
Patient-reported outcomes on DirectMeds align closely with clinical trial averages. Common reports from patients who complete 3–6 months of treatment at therapeutic doses:
- 15–25 lbs lost in the first 3 months for many patients
- 30–50+ lbs over 6–12 months for patients who reach and maintain the 2.4mg dose
- Significant reduction in appetite and food cravings, often described as "food noise going away"
- Side effects (nausea primarily) most pronounced in weeks 2–6, improving significantly by month 3
A meaningful minority of patients report limited results — typically those who had difficulty tolerating dose increases or stopped before reaching therapeutic doses. Non-response to semaglutide is real; switching to tirzepatide produces results for many of these patients.
How DirectMeds compares to other platforms by patient review
| Factor | DirectMeds | Typical competitor |
|---|---|---|
| Pricing satisfaction | High — transparent and competitive | Mixed — varies significantly |
| Medication effectiveness | Consistent with clinical expectations | Same — active ingredient identical |
| Physician quality | Generally positive — real MD review | Variable — some platforms more automated |
| Support responsiveness | Mixed — common industry complaint | Similar across the category |
| Billing/cancellation record | BBB rating: F | Varies; not all competitors disclosed here |
| Shipping speed | Generally 1–2 days, free priority | Often 5–7 days industry-wide |
Seen enough to decide?
Check your eligibility free — no commitment, takes about 2 minutes.
Check eligibility at DirectMeds →Our editorial assessment
Patient reviews of DirectMeds are consistent with our independent evaluation of the platform, with one caveat worth restating rather than glossing over: the gap between the strongly positive Trustpilot sentiment and the BBB's F rating is real and larger than a "typical industry complaint pattern." The medication works because compounded semaglutide at appropriate doses produces the same clinical outcomes as brand-name versions — that part of the patient sentiment holds up. The billing and cancellation complaints are also real, sourced independently, and worth understanding before you enroll, not just after.
DirectMeds remains competitively rated for 2026 based on transparent pricing and genuine physician oversight — but "competitively rated" here means going in with clear eyes about the full record, not an unqualified endorsement. See our full DirectMeds review and our complete legitimacy investigation for the details behind every claim on this page.
Check your eligibility at DirectMeds
Free eligibility check. Licensed physician review. Compounded semaglutide from $249/month.
Check eligibility at DirectMeds →